logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9624166 B1

PDFFull Text
Date of Patent:
Apr. 18, 2017

Filed:

Aug. 27, 2010

Tetracycline compounds

Applicants:

Yonghong Deng, Watertown, MA (US);

Louis Plamondon, Belmont, MA (US);

Cuixiang Sun, Watertown, MA (US);

Xiao-yi Xiao, San Diego, CA (US);

Jingye Zhou, Belmont, MA (US);

Joyce A. Sutcliffe, Newton, MA (US);

Magnus P. Ronn, Melrose, MA (US);

Inventors:

Yonghong Deng, Watertown, MA (US);

Louis Plamondon, Belmont, MA (US);

Cuixiang Sun, Watertown, MA (US);

Xiao-Yi Xiao, San Diego, CA (US);

Jingye Zhou, Belmont, MA (US);

Joyce A. Sutcliffe, Newton, MA (US);

Magnus P. Ronn, Melrose, MA (US);

Assignee:

Tetraphase Pharmaceuticals, Inc., Watertown, MA (US);

Attorney:

Foley Hoag LLP

Primary Examiner:

Sabiha N Qazi

Int. Cl.
CPC ...
A61K 31/65 (2006.01); A61P 31/04 (2006.01); C07C 237/26 (2006.01); C07C 311/08 (2006.01); C07C 307/10 (2006.01); C07C 311/09 (2006.01); C07C 311/13 (2006.01); C07C 311/21 (2006.01); C07C 311/29 (2006.01); C07C 311/44 (2006.01); C07D 205/04 (2006.01); C07D 207/12 (2006.01); C07D 207/16 (2006.01); C07D 209/44 (2006.01); C07D 209/52 (2006.01); C07D 211/54 (2006.01); C07D 211/60 (2006.01); C07D 213/70 (2006.01); C07D 213/74 (2006.01); C07D 213/82 (2006.01); C07D 223/06 (2006.01); C07D 231/18 (2006.01); C07D 233/60 (2006.01); C07D 233/84 (2006.01); C07D 295/15 (2006.01); C07D 307/64 (2006.01);
U.S. Cl.
CPC ...
C07C 311/08 (2013.01); C07C 237/26 (2013.01); C07C 307/10 (2013.01); C07C 311/09 (2013.01); C07C 311/13 (2013.01); C07C 311/21 (2013.01); C07C 311/29 (2013.01); C07C 311/44 (2013.01); C07D 205/04 (2013.01); C07D 207/12 (2013.01); C07D 207/16 (2013.01); C07D 209/44 (2013.01); C07D 209/52 (2013.01); C07D 211/54 (2013.01); C07D 211/60 (2013.01); C07D 213/70 (2013.01); C07D 213/74 (2013.01); C07D 213/82 (2013.01); C07D 223/06 (2013.01); C07D 231/18 (2013.01); C07D 233/60 (2013.01); C07D 233/84 (2013.01); C07D 295/15 (2013.01); C07D 307/64 (2013.01); C07C 2101/02 (2013.01); C07C 2101/04 (2013.01); C07C 2101/08 (2013.01); C07C 2101/14 (2013.01); C07C 2103/40 (2013.01); C07C 2103/44 (2013.01);
Abstract

The present invention is directed to a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.

Find Patent Forward Citations

Loading…